July 27, 2016 / 11:37 AM / a year ago

BRIEF-Loblaw sees $1.3 billion in 2016 capital expenditures

July 27 (Reuters) - Loblaw Companies Ltd

* Qtrly adjusted diluted net earnings per common share were $1.01

* Qtrly drug retail (shoppers drug mart) same-store sales growth was 4.0%

* Q2 retail segment sales were $10,494 million, an increase of $176 million, or 1.7%, compared to q2 of 2015

* To return capital to shareholders by allocating a significant portion of free cash flow to share repurchases in 2016

* Sees for 2016 approximately $1.3 billion in capital expenditures

* Q2 earnings per share view c$0.94, revenue view c$10.75 billion -- Thomson Reuters I/B/E/S

* Fy2016 earnings per share view c$3.86, revenue view c$46.57 billion -- Thomson Reuters I/B/E/S

* Says

* Qtrly revenue was $10,731 million, an increase of $196 million, or 1.9%, compared to q2 of 2015

* Qtrly diluted net earnings per common share were $0.39

* Qtrly food retail (loblaw) same-store sales growth was 0.7%, excluding gas bar

* Says recorded an additional charge related to store closures of approximately $43 million in q2

* In 2016 to deliver positive same-store sales and stable gross margin in its retail segment

* Says in 2016, company expects to grow adjusted net earnings Source text for Eikon: Further company coverage: (Bengaluru Newsroom +1-646-223-8780)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below